India Malaria Diagnostics Market Share, Size & Trends 2031
India Malaria Diagnostics Market Share, Size & Trends 2031
Segments - India Malaria Diagnostics Market by Technology (Rapid Diagnostic Tests, Microscopy, and Molecular Diagnostic Tests [Conventional PCR and Real-time PCR]) and End-users (Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, and Academic & Research Institutes) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031
Upcoming
| Report ID :HC-1089
| 4.4 Rating
| 65 Reviews
| 169 Pages
| Format :
Report Description
India Malaria Diagnostics Market Outlook 2031
The India malaria diagnostics market size was valued at USD 22.28 Million in 2022 and is projected to reach USD 35.77 Million by 2031 register a substantial CAGR 5.4% during the forecast period, 2023–2031. The growth of the market is attributed to the increase in the incidence of malaria and growing development of advanced malaria diagnostic facilities and devices in the country.
In India, malaria is one of the major healthcare problems that has taken several thousands of lives especially in the rural areas. The disease is majorly caused by Plasmodium vivax and Plasmodium falciparum. P. vivax parasites transmitted through mosquitos. According to a data published by National Center for Biotechnology Information (NCBI), malaria vector known as Anopheles culicifacies s.l. is the main responsible for an estimated 65% of malaria cases in India.
Chhattisgarh, Odisha, Madhya Pradesh, and Maharashtra are some of the major states of India that have a record high incidences of the disease every year. Inadequate health infrastructure in the rural areas and lack of preventive measures from the disease in the hilly and forest areas of these states lead to the perennial transmission of malaria.
Additionally, as per a report published by World Health Organization (WHO), combining the 15 countries in Sub-Saharan Africa and India represented over 80% of the global malaria burden and India was the only country where cases of urban malaria were observed till date. Moreover, these countries constituted around 80% of the global malarial deaths.
The need for rapid diagnosis and subsequent treatment plans are widely considered to prevent the spread of the disease in India. Introduction of novel diagnostic products such as Becton, Dickinson, and Co.’s SightDX platform is considered to be a major development for rapid diagnosis and quick sample preparation.
India Malaria Diagnostics Market Drivers, Restraints, Trends, and Opportunities
- Increasing incidence of malaria among a large number of the population in the country including semi-urban areas is a key factor projected to drive the market growth during the forecast period.
- Rising adoption of advanced and easy diagnostic tools for detecting malaria in the country is projected to boost the market growth during the forecast period.
- Rapid technological advancements providing high-efficient and cost-effective diagnosis are major factors that can propel the market growth.
- Several favorable policies and initiatives by government bodies to encourage extensive researches to prevent and curb the menace of malaria in India are key opportunities for the market expansion in the country.
- The outbreak of COVID-19 pandemic had affected the market as several manufacturers are focusing to meet the rising demand for Sars-Cov-2 diagnostics kits and devices. This is expected to hamper the market growth.
- Lack of skilled professionals and specialized laboratories cause low adoption of the diagnostics. This is expected to restrain the market growth.
Scope of The India Malaria Diagnostics Market Report
The report on India malaria diagnosis market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Malaria Diagnosis Market - India Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Technology (Rapid Diagnostic Tests, Microscopy, and Molecular Diagnostic Tests [Conventional PCR and Real-time PCR]) and End-Users (Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, and Academic & Research Institutes) |
|
Country Scope |
India |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, Beckman Coulter, Inc., Access Bio, Inc., Premier Medical Corporation Pvt. Ltd., Olympus Corporation, Nikon Corporation, J. Mitra & Co. Pvt. Ltd., Tulip Diagnostics Ltd., and Microgene Diagnostic Systems Pvt. Ltd. |
India Malaria Diagnosis Market Segment Insights
Molecular diagnostics segment to represent a considerable market share
On the basis of technologies, the market is segregated into Rapid Diagnostic Tests (RDTs), microscopy, and molecular diagnostic tests. The molecular diagnostic tests segment is further divided into conventional PCR and real-time PCR (qPCR or quantitative PCR). The molecular diagnostics tests segment is projected to represent a considerable market share during the forecast period owing to the accurate diagnosis offered by these tests.
The real-time PCR test is carried out by using DNA extracted from the blood samples and is used for the detection of low platelet count. On the other hand, the microscopy segment is projected to expand at a healthy CAGR during the forecast period owing to the increase in the use of microscopy techniques for the diagnosis of the disease. The microscopy technique is a reliable and traditional method used for the malaria disease diagnosis.
The presence of malarial parasites such as P. malaria, P. vivax, P. falciparum, and P. ovale, which are responsible for this virus transmission, are mostly identified using this technique. Additionally, parasite density can be used to design treatment plans accordingly. The RDTs segment, however, is anticipated to witness an impressive growth during the forecast period as it is used for the detection of specific malaria antigens from the blood sample by using a test card.
The appearance of specific bands in the test card primarily indicates the presence of infection with either of the human malarial parasites. These RDTs are able to detect P. falciparum, P. malariae, P. ovale, and P. vivax species of human malaria. Malarial RDTs are generally used where microscopy examination is not possible, specifically, in remote areas having limited access to high-quality microscopy services and healthcare infrastructure.
Hospitals & clinics segment to constitute a significant market share
Based on end-users, the market is segmented into hospitals & clinics, diagnostic laboratories, blood banks, and academic & research institutes. The hospitals & clinics segment is anticipated to constitute a significant market share during the forecast period. The majority of the population depends on these long-term facilities for diagnosis, treatment, and management of diseases.
Factors such as the availability of diagnostic devices, growing awareness, and experienced healthcare professionals ensures easy and effective treatment of malaria in urban areas of the country are expected to boost the segment growth.
The disease outbreak in urban areas is owing to the prolonged rainfall and climatic changes that provide favorable temperature and climate conditions for the growth of Anopheles mosquitoes. Most of the urban population in India have tendency to seek treatment in hospitals and privatized healthcare clinics that are well equipped with advanced techniques and offering timely treatment.
The blood banks segment, on the other hand, is projected to expand at an impressive CAGR during the forecast period. For infectious diseases such as malaria, influenza and dengue, the blood donors are inquired about the recent visits to endemic regions. In most of the cases, RDTs are used for primary screening tests and serological tests, which are generally done post confirmatory results. Blood samples are analyzed to detect malaria and other diseases illness that may require to be identified before blood transfusions.
Segments
The India malaria market has been segmented on the basis of
Technology
- Rapid Diagnostic Tests
- Microscopy
- Molecular Diagnostic Tests
End-Users
- Hospitals & Clinics
- Diagnostic Laboratories
- Blood Banks
- Academic & Research Institutes
Country
- India
Key Players
- Abbott Laboratories
- Siemens Healthineers
- Bio-Rad Laboratories
- Beckman Coulter, Inc.
- Access Bio, Inc.
- Premier Medical Corporation Pvt. Ltd.
- Olympus Corporation
- Nikon Corporation
- J. Mitra & Co. Pvt. Ltd.
- Tulip Diagnostics Ltd.
- Microgene Diagnostic Systems Pvt. Ltd.
Competitive Landscape
Some of the key players competing in India malaria diagnostics market include Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, Beckman Coulter, Inc., Access Bio, Inc., Premier Medical Corporation Pvt. Ltd., Olympus Corporation, Nikon Corporation, J. Mitra & Co. Pvt. Ltd., Tulip Diagnostics Ltd., and Microgene Diagnostic Systems Pvt. Ltd.
These key players are focusing on product launches and strategic collaborations to improve their market presence and acquire a large a market share. For instance, in 2016, Becton, Dickinson & Company announced the launch of Parasight Malaria Detection Platform for hospitals and pathology labs in India. It was a computer vision platform, which automatically analyzes the sample and also generates results in lesser time period.
In February 2018, Siemens Healthineers India collaborated with an Indian startup Jana Care to launch a smartphone-based diagnostic platform called Aina. This diagnostic platform can be used in smartphones and helps in reading paper strips of all kinds, which enables affordable and accurate testing in any healthcare setting.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Malaria Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Malaria Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Malaria Diagnostics Market - Supply Chain
4.5. Global Malaria Diagnostics Market Forecast
4.5.1. Malaria Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Malaria Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Malaria Diagnostics Market Absolute $ Opportunity
5. Global Malaria Diagnostics Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Malaria Diagnostics Market Size and Volume Forecast by End Users
5.3.1. Hospitals & Clinics Diagnostic Laboratories Blood Banks Academic & Research Institutes
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Malaria Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Malaria Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Malaria Diagnostics Demand Share Forecast, 2019-2026
7. North America Malaria Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Malaria Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Malaria Diagnostics Market Size and Volume Forecast by End Users
7.4.1. Hospitals & Clinics Diagnostic Laboratories Blood Banks Academic & Research Institutes
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Malaria Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Malaria Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Malaria Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Malaria Diagnostics Market Size and Volume Forecast by End Users
8.4.1. Hospitals & Clinics Diagnostic Laboratories Blood Banks Academic & Research Institutes
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Malaria Diagnostics Demand Share Forecast, 2019-2026
9. Europe Malaria Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Malaria Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Malaria Diagnostics Market Size and Volume Forecast by End Users
9.4.1. Hospitals & Clinics Diagnostic Laboratories Blood Banks Academic & Research Institutes
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Malaria Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Malaria Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Malaria Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Malaria Diagnostics Market Size and Volume Forecast by End Users
10.4.1. Hospitals & Clinics Diagnostic Laboratories Blood Banks Academic & Research Institutes
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Malaria Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Malaria Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Malaria Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Malaria Diagnostics Market Size and Volume Forecast by End Users
11.4.1. Hospitals & Clinics Diagnostic Laboratories Blood Banks Academic & Research Institutes
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Malaria Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Malaria Diagnostics Market: Market Share Analysis
12.2. Malaria Diagnostics Distributors and Customers
12.3. Malaria Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott Laboratories Siemens Healthineers Bio-Rad Laboratories Beckman Coulter, Inc. Access Bio, Inc. Premier Medical Corporation Pvt. Ltd. Olympus Corporation Nikon Corporation&
Methodology
Related Reports
Some other reports from this category!
Our Clients
